Today's Top 20 Gastroenterology and Endoscopy Stories
-
Pharmaceutical company taps former FDA gastroenterology director
Pharmaceutical company Jaguar Health added Andrew Mulberg, MD, former deputy director of the division of gastroenterology and inborn errors products at the FDA, as a consultant. -
7 endoscopy updates
Here are seven endoscopy updates Becker's has reported on since Jan. 3: -
4 colonoscopy updates in 2 weeks
From a celebrity colonoscopy to a major data breach, here are four colonoscopy updates from 2023. -
How colonoscopy reimbursement is expected to change for ASCs in 2023
Medicare ASC payments for colonoscopies with lesion removals and colonoscopies and biopsies are expected to increase in 2023, according to VMG Health's "ASCs in 2022: A Year in Review" report released Jan. 26. -
The growth of GI Alliance: A timeline
In November, 2018, Southlake, Texas-based management services company GI Alliance was formed through a partnership between Waud Capital Partners and Texas Digestive Disease Consultants. -
GI Alliance partners with Connecticut GI
Dallas-based GI Alliance, a gastroenterology management organization, has partnered with Rocky Hill-based Connecticut GI. -
Healthcare scribe certification program to add gastroenterology
The American Healthcare Documentation Professionals Group, a healthcare documentation trainer and certifier, will now offer a gastroenterology program for certified medical scribe professionals. -
Gastro Health, GI Alliance and more: Who had the most transactions in 2022?
Becker's reported on eight Gastro Health transactions in 2022. -
Kroger launches personalized medicine trial for gut and immune health
Kroger Health, the healthcare division of national grocery chain Kroger Co., has begun active recruitment for colorectal cancer gut and immune health observation. -
Gayle King gets colonoscopy, urges others to follow suit
Gayle King, CBS Mornings co-host and editor-at-large at Oprah Daily, shared via Instagram that she received a colonoscopy and has encouraged others to follow suit. -
Virginia lawmakers push for greater coverage of colon cancer screening costs
The Virginia House of Delegates is pushing to pass a bill that would require health insurance companies to cover all costs for colorectal cancer screenings ABC affiliate WSET reported Jan. 24. -
33% of pediatric gastroenterologists report burnout: study
A study published Jan. 1 in the Journal of Pediatric Gastroenterology and Nutrition concluded that pediatric gastroenterologists are at risk for emotional exhaustion, depersonalization and overall burnout. -
UC San Diego Health earns endoscopy unit award
The University of California San Diego Health's endoscopy program has been recognized by the American Society for Gastrointestinal Endoscopy for its commitment to quality and safety. -
16 gastroenterology updates
From an FDA approval to several gastroenterologists joining new facilities, here are 16 gastroenterology updates Becker's has reported on since Jan. 13: -
Cleveland hospital 1st in Midwest to perform awake pediatric endoscopy with EvoEndo system
Cleveland-based UH Rainbow Babies and Children's is the first facility in the Midwest to complete an awake pediatric endoscopy using the EvoEndo system. -
AGA invests in endoscopic ultrasound device company
Medical device company EndoSound has received an investment from the American Gastroenterological Association's venture capital fund to expand and improve its endoscopic ultrasound technology. -
Michigan Medicine gastroenterologist no longer works at university amid falsified data allegations
Chung Owyang, MD, a former gastroenterology researcher at Ann Arbor-based Michigan Medicine, no longer works for Ann Arbor-based University of Michigan after allegedly falsifiying or fabricating data in multiple publications, MLive reported Jan. 24. -
Austin Gastroenterology opens new Leander clinic
Austin Gastroenterology has opened a new clinic in Leander, Texas, according to a Jan. 23 report from the Community Impact. -
FDA approves drug for treatment-resistant metastatic colorectal cancer
The FDA has approved the use of tucatinib — a drug engineered by biotech company Seagen — in tandem with trastuzumab as a second-line treatment for colorectal cancer that has not responded to other therapies. -
5 gastroenterologists to know
Here are five physicians to know who specialize in gastroenterology:
Page 1 of 174